Medtronic posts Q1 earnings beat, raises full-year outlook

Shares of Medtronic (MDT) are on the move after the company delivered a first quarter earnings beat on both revenue and profit. Revenue came in at $7.91 billion, slightly above the projected $7.9 billion. Adjusted earnings per share were reported at $1.23, topping the $1.20 expected by analysts.

Additionally, Medtronic also raised its full-year guidance, sending shares higher.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written by Angel Smith

Video transcript

All right.

And then moving on to our final training ticker that is med tronic that stock moving higher today after first quarter earnings beating it was moving more earlier in the session.

But it did see momentum in its diabetes device business which boosted the company's organic growth Metronic also slightly raised its guidance for the year as you can see was up more earlier in the session and has lost some momentum here.

Potentially could be.

We're gonna talk about this story later in the show, Eli Lily coming out with some positive diabetes results for its Z bound drug that had hit diabetes related drugs.

So maybe that took some of the air out of Medronic as well because generally if you look at the what the company did and the analyst reaction, it's pretty positive.

Yeah.

And also said Bloomberg to your point to saying, listen to them, it looked like they have navigated China headwinds to raise.

They said the low end of fiscal 25 revenue and eps guidance as other med tech companies they pointed out actually had to pair theirs um stock.

If you pull back the chart, it hasn't done much this year, it's, it's, you know, about, about 5 6% the XL V just in contrast healthcare ETF up about 13% or so.